The borderline cervical smear: Colposcopic and biopsy outcome

Journal of Clinical Pathology

Volumn 53, Issue 6, 2000, Pages 439-444

  Al Nafussi, Awatif ^a   Rebello, Gemma ^a   Al Yusif, Raja ^a   McGoogan, Euphemia ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Borderline nuclear abnormality; Cervical cytology

Indexed keywords

ARTICLE; COLPOSCOPY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

ADULT; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COLPOSCOPY; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; UNNECESSARY PROCEDURES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0034091383     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.53.6.439     Document Type: Article

References (29)

1. 1 Evans DMD, Hudson EA, Brown CL, et al. Terminology in gynaecological cytopathology: report of the working party of the BSCC. J Clin Pathol 1986;39:933-44.
2. 2 Herbert A. Achievable standards, bench marks for reporting and criteria for evaluating cervical cytopathology: report of a working party set up by RCPath, BSCC and NHSCSP. October 1995, Publication No. 1. Sheffield: NHSCSP Publications.
3. 3 Buckley CH, Herbert A, Johnson J, et al. Borderline nuclear changes in cervical smears: guidelines on their recognition and management. J Clin Pathol 1994;47:481-92.
4. 4 National Cancer Institute. National Cancer Institute workshop report: the 1988 Bethesda system for reporting cervical/vaginal cytology diagnoses. JAMA 1989;262: 931.
5. 5 Pritchard J. Quality assurance guidelines for the cervical screening programme. Report of a working party convened by the NHS Cervical Screening Programme. NHSCP Publication No 3, January 1996. Sheffield: NHSCSP Publications.
6. 6 Jones MH, Singer A, Jenkins D. The mildly abnormal cervical smear - patients' anxiety and choice of management. J R Soc Med 1996;89:257-60.
7. 7 Kohan S, Nouinoff J, Beckman EM, et al. Colposcopic screening of women with atypical Papanicolaou smears. J Reprod Med 1985;30:383-7.
8. 8 Maier RC, Schultenover SJ. Evaluation of the atypical squamous cell Papanicolaou smear. Int J Gynecol Pathol 1986;5:242-8.
9. 9 Noumoff JS. Atypia in cervical cytology as a risk factor for intraepithelial neoplasia. Am J Gynecol 1987;156:628-31.
10. 10 Davis GL, Hernandez E, Davis JL, et al. Atypical squamous cells in Papanicolaou smears. Obstet Gvnecol 1987;69:43-6.
11. 11 Jones DED, Creasman WT, Dombroski RA, et al. Evaluation of the atypical Pap smear. Am J Obstet Gynecol 1987;157:544-9.
12. 12 Morrison BW, Erickson ER, Doshi N, et al. The significance of atypical cervical smears. J Reprod Med 1988;33:809-12.
13. 13 Kaminski PF, Stevens CW Jr, Wheelock JB. Squamous atypia on cytology: the influence of age. J Reprod Med 1989;34:617-20.
14. 14 Soofer SB, Sidawy MK. Reactive cellular change: is there an increased risk for squamous intraepithelial lesions? Cancer 1997;181:144-7.
15. 15 Stastny JF, Remmers RE, London WB, et al. Atypical squamous cells of undetermined significance: a comparative review of original and automated rescreen diagnosis of cervical smears with long term follow-up. Cancer 1997;81: 348-53.
16. 16 Selvaggi SM, Haefner HK. Reporting of atypical squamous cells of undetermined significance on cervical smears: is it significant? Diagn Cytopathol 1995;13:352-6.
17. 17 Williams ML, Rimm DL, Pedigo MA, et al. Atypical squamous cells of undetermined significance: correlative histologic and follow-up studies from an academic medical centre. Diagn Cytopathol 1998;16:1-7.
18. 18 Sherman ME, Schiffman MH, Lornice AT, et al. Toward objective quality assurance in cervical cytopathology. Am J Clin Pathol 1994;102:182-7.
19. 19 Mitchell H, Medley G. Differences between Papanicolaou smears with correct and incorrect diagnosis. Cytopathology 1995;6:368-75.
20. 20 O'Sullivan JP, A'Hern RP, Chapman PA, et al. A case-control study of true-positive versus false-negative cervical smears in women with cervical intraepithelial neoplasia (CIN) III. Cytopathology 1998;9:155-61.
21. 21 Bergeron C, Debaque H, Ayivi J, et al. Cervical smear histories of 585 women with biopsy-proven carcinoma in situ. Acta Cytol 1997;41:676-80.
22. 22 Sheils LA, Wilbur DC. Atypical squamous cells of undetermined significance: stratification of the risk of association with, or progression to, squamous intraepithelial lesions based on morphologic subcategorization. Acta Cytol 1997; 41:1065-72.
23. 23 Klin MI, Davey D. Atypical squamous cells of undetermined 1996 significance qualified: a follow-up study. Diagn Cytopathol 1996;14:380-4.
24. 24 Solomon D, Frable W, Vooijs GP, et al. ASCUS and AGUS criteria: IAC task force summary. Acta Cytol 1998;42:16-24.
25. 25 Abati A, Jaffurs W, Wilder AM. Squamous atypia in atrophic vaginal smear. Cancer (Cancer Cytology) 1998;84: 218-25.
26. 26 Hirschowitz L, Raffle AK, Mackenzie EFD, et al. Long term follow up of women with borderline cervical smear-test results: effects of age and viral infection on progression to high grade dyskaryosis. BMJ 1992;304:1209-12.
27. 27 Medley G, Surtees VM. Squamous atypia in atrophic vaginal smear cancer [editorial counterpoint]. Cancer (Cancer Cytology) 1998;84:200-1.
28. 28 Symmans K, Mechanic L, MacCormell P, et al. Correlation of cervical cytology and human papillomavirus DNA detection in postmenopausal women. Int J Gynecol Pathol 1992;11:204-9.
29. 29 Kaminski PF, Sorosky JI, Wheelock JB, et al. The significance of atypical cervical cytology in an older population. Obstet Gynecol 1989;73:13-15.